Immunological Aspects of Latent Tuberculosis Infection in Diabetes Mellitus
DOI:
https://doi.org/10.36497/jri.v41i4.219Keywords:
DM, tuberculosis, Latent tuberculosis infection (LTBI), immune mechanismAbstract
Abstract
The interaction of diabetes mellitus (DM) with tuberculosis (TB) is currently a health concern. Diabetes mellitus is one of the main risk factors for TB infection to become latent TB and / or progress to active TB. Immune mechanisms contribute to this increased risk. The disruption of the mycobacteria recognition process, phagocyte activity and cellular activity will affect the disruption of cytokine and chemokine production. Hyperglycemia that occurs will result in delayed adaptive immune response resulting in reduced Th1, Th2, and Th17 cells as well as the cytokines produced by these cells that play a role in macrophage activation and TB inflammatory response. Understanding of the immune mechanisms that underlie the sensitivity of DM to TB infection, especially latent TB, will facilitate the implementation of strategies in screening and therapy to deal with the double burden of both diseases. The purpose of this literature study focuses on the relationship of DM with latent TB infection in terms of immunology.Downloads
References
Kementerian Kesehatan RI. Konsesus pengelolaan tuberkulosis dan diabetes mellitus (TB-DM) di Indonesia. Jakarta: Kementerizn Kesehatan RI; 2015.
World Health Organizations. Tuberculosis 2020. World Health Organizations.[online]. 2020 [Cited 2020 Nov 23]. Available from URL: http:/www.who.int/tb/publication/2020
Saedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, eta all. Global and regional Diabetes Prevalence Estimates for 2019 and projection for 2030 and 2045: Result From the International Diabetes federation Diabetes Atlas. Diab Res Clinc Pract. 2019;157: 10
World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. Stop TB Department and Department of Chronic Diseases and Health Promotion World Health Organization, Geneva, Switzerland and The International Union Against Tuberculosis and Lung Disease, Paris, France. 2011.p.1–35.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observasional study. Plos Med. 2008;5(7):e153.
Patra J, Jha P, Rehm J, Suraweera W. Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: Individual participant data (IPD) meta-analyses of 72,684 individuals in 14 high tuberculosis burden countries. PLoS One. 2014;9(5):e96433.
Salgame P, Geadas C, Collins L, Jones-López E, Ellner JJ. Latent tuberculosis infection - Revisiting and revising concepts. Tuberculosis. 2015;95(4):373–84.
Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol Mech Dis. 2012;7(1):353–84.
Sia JK, Georgieva M, Rengarajan J. Innate immune defenses in human tuberculosis: An overview of the interactions between Mycobacterium tuberculosis and innate immune cells. J Immunol Res. 2015; 747543:1–12.
Dutta NK, Karakousis PC. Latent tuberculosis infection : Myths, models , and molecular mechanisms. Microbiol Mol Bio. 78(3):343–71.
Schwander S, Dheda K. Human lung immunity against Mycobacterium tuberculosis: Insights into pathogenesis and protection. Am J Respir Crit Care Med. 2011;183(6):696–707.
Esmail H, Barry CE, Young DB, Wilkinson RJ. The ongoing challenge of latent tuberculosis. Philos Trans R Soc B Biol Sci. 2014;369(1645):1–11.
Pal R, Ansari MA, Hameed S, Fatima Z. Diabetes mellitus as hub for tuberculosis infection: A snapshot. Int J Chronic Dis. 2016;Article ID 5981574:1–7.
García-Elorriaga G1, Del Rey-Pineda G. Type 2 diabetes mellitus as a risk factor for tuberculosis. Mycobact Dis. 2014;04(02):2–7.
Leow MKS, Dalan R, Chee CBE, Earnest A, Chew DEK, Tan AWK, et al. Latent tuberculosis in patients with diabetes mellitus: Prevalence, progression and public health implications. Exp Clin Endocrinol Diabetes. 2014;122(9):528–32.
Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observasional study. Plos Med. 2008;5(7):e153.
Segura-Cerda CA, Lopez-Romero W, Flores-Valdez MA. Changes in Host Response to Mycobacterium tuberculosis Infection associated With Type 2 Diabetes: Beyond hyperglycemia. Front Cell Infect Microbiol. 2019;9(342):1 ̶ 9
Lopez-Lopez N, Martinez AGR, Garcia-Hernandez MH, Hernandez PR, Castaneda-Delgado, JE, Lugo-Villarino G, et al. Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis. Mem Inst Oswaldo Cruz.2018;113:e170326.
Kumar NP, Moideen K, Bhootra Y, Nancy A, Viswanathan V, Shruthi BS, et al. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. Immunology.2019;156:249–58.
Almeida-Junior JL, Gil-Santana L, Oliveira CA, Castro S, Cafezeiro AS, Daltro C, et al. Glucose metabolism disorder is associated with pulmonary tuberculosis in individuals with respiratory symptoms from Brazil.PLoS ONE. 2016:11:e0153590.
Vrieling F, Wilson L, Rensen PCN, Walzl G, Ottenhoff THM, Joosten SA. Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction. PLoS Pathog. 2019;15:e1007724.
Nathela PK, Babu S. Influence of Diabetes on Immunity to Human Tuberculosis. Immunology. 2017; 152:13 ̶ 24.
Lee MC, Chiang CY, Lee CH, Ho CM, Chang CH, Wang JY, et al. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: a nationwide cohort study with validated diagnostic criteria. PLoS ONE.2018;13:e0205807.
Arliny Y. Prediktor diagnosis tuberkulosis aktif pada penyandang diabetes melitus dengan tuberkulosis laten: kajian terhadap cathelicidin dan 1,25 dihidroxyvitamin D3. Disertasi.2020
Urgate-Gil C, Alisjahbana B, Ronacher K, et al. Diabetes mellitus among pulmonary tuberculosis patients from 4 tuberculosis-endemic countries: The TANDEM study. Clin Infect Dis. 2019;ciz284.
Kumar NP, Moideen K, George PJ, Dolla C, Kumaran P, Babu S. Impaired cytokine but enhanced cytotoxic marker expression in Mycobacterium tuberculosis-induced CD8+ T cells in individuals with type 2 diabetes and latent Mycobacterium tuberculosis infection. J Infect Dis 2016; 213:866–70
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
